{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:28:35Z","timestamp":1791289715878,"version":"4.3.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.tmaid.2014.10.021","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T05:54:05Z","timestamp":1415080445000},"page":"80-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Acute and long-term psychiatric side effects of mefloquine: A follow-up on Danish adverse event reports"],"prefix":"10.1016","volume":"13","author":[{"given":"\u00c5sa","family":"Ringqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"Glenth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskild","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tmaid.2014.10.021_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1708-8305.1999.tb00843.x","article-title":"Mefloquine for malaria chemoprophylaxis 1992\u20131998: a review","volume":"6","author":"Schlagenhauf","year":"1999","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2014.10.021_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1475-2875-9-357","article-title":"The position of mefloquine as a 21st century malaria chemoprophylaxis","volume":"9","author":"Schlagenhauf","year":"2010","journal-title":"Malar J"},{"issue":"6077","key":"10.1016\/j.tmaid.2014.10.021_bib3","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1136\/bmj.1.6077.1626","article-title":"Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria","volume":"1","author":"Hall","year":"1977","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.tmaid.2014.10.021_bib4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4269\/ajtmh.1980.29.1131","article-title":"Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol)","volume":"29","author":"Pearlman","year":"1980","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.tmaid.2014.10.021_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4269\/ajtmh.1986.35.246","article-title":"Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine\/sulfadoxine\/pyrimethamine on the Thai-Kampuchean border","volume":"35","author":"Meek","year":"1986","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.tmaid.2014.10.021_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2165\/00003088-199019040-00002","article-title":"Clinical pharmacokinetics of mefloquine","volume":"19","author":"Karbwang","year":"1990","journal-title":"Clin Pharmacokinet"},{"issue":"7423","key":"10.1016\/j.tmaid.2014.10.021_bib7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bmj.327.7423.1078","article-title":"Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study","volume":"327","author":"Schlagenhauf","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.tmaid.2014.10.021_bib8","first-page":"CD006491","article-title":"Drugs for preventing malaria in travellers","author":"Jacquerioz","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"10.1016\/j.tmaid.2014.10.021_bib9","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.297.20.2251","article-title":"Controversies and misconceptions in malaria chemoprophylaxis for travelers","volume":"297","author":"Chen","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.tmaid.2014.10.021_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00002018-200427030-00005","article-title":"The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials","volume":"27","author":"Meier","year":"2004","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.tmaid.2014.10.021_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tmaid.2013.02.008","article-title":"Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders","volume":"11","author":"Schneider","year":"2013","journal-title":"Travel Med Infect Dis"},{"issue":"6","key":"10.1016\/j.tmaid.2014.10.021_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00228-002-0492-z","article-title":"Neuropsychiatric events during prophylactic use of mefloquine before travelling","volume":"58","author":"van Riemsdijk","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.tmaid.2014.10.021_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1708-8305.2008.00272.x","article-title":"Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study","volume":"16","author":"Schlagenhauf","year":"2009","journal-title":"J Travel Med"},{"issue":"3","key":"10.1016\/j.tmaid.2014.10.021_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1067\/mcp.2002.127113","article-title":"Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events","volume":"72","author":"van Riemsdijk","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tmaid.2014.10.021_bib15","series-title":"SCL-90-R: symtom checklist-90-R. Administration, scoring and procedures manual","author":"Derogatis","year":"1994"},{"key":"10.1016\/j.tmaid.2014.10.021_bib16","series-title":"Clinical psychometrics","author":"Bech","year":"2012"},{"key":"10.1016\/j.tmaid.2014.10.021_bib17","first-page":"537","volume":"vol. 7","author":"Derogatis","year":"2000"},{"issue":"6","key":"10.1016\/j.tmaid.2014.10.021_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1600-0447.2005.00743.x","article-title":"Mental distress in the Danish general population","volume":"113","author":"Olsen","year":"2006","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"10.1016\/j.tmaid.2014.10.021_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0447.2004.00399.x","article-title":"The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample","volume":"110","author":"Olsen","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.tmaid.2014.10.021_bib20","series-title":"PSE, kort version til klinisk brug (Danish version of present state examination, short version for clinical use)","author":"WHO","year":"1999"},{"issue":"6","key":"10.1016\/j.tmaid.2014.10.021_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archpsyc.1990.01810180089012","article-title":"SCAN. Schedules for clinical assessment in neuropsychiatry","volume":"47","author":"Wing","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.tmaid.2014.10.021_bib22","series-title":"SF-36 h\u00e4lsoenk\u00e4t: svensk manual och tolkningsguide (Swedish manual and interpretation guide)","author":"Sullivan","year":"1994"},{"issue":"6","key":"10.1016\/j.tmaid.2014.10.021_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.tmaid.2014.10.021_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mpr.145","article-title":"Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-five well-being scale","volume":"12","author":"Bech","year":"2003","journal-title":"Int J Methods Psychiatr Res"},{"issue":"11","key":"10.1016\/j.tmaid.2014.10.021_bib25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0895-4356(98)00092-4","article-title":"Tests of data quality, scaling assumptions, and reliability of the Danish SF-36","volume":"51","author":"Bjorner","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.tmaid.2014.10.021_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0895-4356(98)00102-4","article-title":"Evaluation of criterion-based validity: results from normative population","volume":"51","author":"Sullivan","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.tmaid.2014.10.021_bib27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuro.2011.01.001","article-title":"Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase","volume":"32","author":"Milatovic","year":"2011","journal-title":"Neurotoxicology"},{"issue":"5","key":"10.1016\/j.tmaid.2014.10.021_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuro.2010.05.005","article-title":"Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons","volume":"31","author":"Hood","year":"2010","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.tmaid.2014.10.021_bib29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1176\/ajp.152.6.833","article-title":"Stressful life events, genetic liability, and onset of an episode of major depression in women","volume":"152","author":"Kendler","year":"1995","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.tmaid.2014.10.021_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-0447.2003.01419.x","article-title":"Life events and depressiveness \u2013 the effect of adjustment for psychosocial factors, somatic health and genetic liability","volume":"107","author":"Romanov","year":"2003","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"10.1016\/j.tmaid.2014.10.021_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.60.8.789","article-title":"Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety","volume":"60","author":"Kendler","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.tmaid.2014.10.021_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/per.808","article-title":"Personality, life events and the course of anxiety and depression","volume":"25","author":"R. K","year":"2011","journal-title":"Eur J Personality Eur J Pers"},{"key":"10.1016\/j.tmaid.2014.10.021_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0447.1989.tb05216.x","article-title":"Repeated incidence and prevalence studies of mental disorders in a total population followed during 25 years. The Lundby Study, Sweden","volume":"348","author":"Hagnell","year":"1989","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"3","key":"10.1016\/j.tmaid.2014.10.021_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0447.2007.01017.x","article-title":"Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981\u20132004","volume":"116","author":"Eaton","year":"2007","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.tmaid.2014.10.021_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/08039480903009118","article-title":"How common are psychotic and bipolar disorders? A 50-year follow-up of the Lundby population","volume":"63","author":"Bogren","year":"2009","journal-title":"Nord J Psychiatry"},{"issue":"3","key":"10.1016\/j.tmaid.2014.10.021_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1017\/S0033291799002044","article-title":"Incidence of depression in the Stirling County Study: historical and comparative perspectives","volume":"30","author":"Murphy","year":"2000","journal-title":"Psychol Med"},{"issue":"4","key":"10.1016\/j.tmaid.2014.10.021_bib37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1017\/S0033291797005308","article-title":"The National Psychiatric Morbidity surveys of Great Britain\u2013initial findings from the household survey","volume":"27","author":"Jenkins","year":"1997","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.tmaid.2014.10.021_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199701000-00003","article-title":"Depression in the community: the first pan-European study DEPRES (Depression Research in European Society)","volume":"12","author":"Lepine","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.tmaid.2014.10.021_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.177.2.149","article-title":"Definition and prevalence of severe and persistent mental illness","volume":"177","author":"Ruggeri","year":"2000","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.tmaid.2014.10.021_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1708-8305.1998.tb00469.x","article-title":"Culture shock and travelers","volume":"5","author":"Stewart","year":"1998","journal-title":"J Travel Med"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893914002129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893914002129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:00:43Z","timestamp":1761487243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893914002129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1477893914002129"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2014.10.021","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and long-term psychiatric side effects of mefloquine: A follow-up on Danish adverse event reports","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2014.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}